CD4 and neoplasm: It is noteworthy that transfer of either primed CD4+ T cells (Fig. 3a), B cells (Fig. 3e), or sera (Fig. 3g) on the day of tumor inoculation provides superior tumor immunity when compared to active immunization on the day when tumors become palpable (Fig. 2b).